User profiles for Rebecca J Fairclough
 | Rebecca FaircloughAssociate Principal Scientist, Bioscience, AstraZeneca Verified email at astrazeneca.com Cited by 1882 |
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
RJ Fairclough, MJ Wood, KE Davies - Nature Reviews Genetics, 2013 - nature.com
Duchenne muscular dystrophy (DMD) is a devastating progressive disease for which there
is currently no effective treatment except palliative therapy. There are several promising …
is currently no effective treatment except palliative therapy. There are several promising …
[HTML][HTML] Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - PloS one, 2011 - journals.plos.org
Background Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
[HTML][HTML] The secretory pathway Ca2+/Mn2+-ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions
…, L Dode, K Van Baelen, RJ Fairclough… - Journal of biological …, 2005 - ASBMB
Accumulation of Ca 2+ into the Golgi apparatus is mediated by sarco(endo)plasmic reticulum
Ca 2+ -ATPases (SERCAs) and by secretory pathway Ca 2+ -ATPases (SPCAs). Mammals …
Ca 2+ -ATPases (SERCAs) and by secretory pathway Ca 2+ -ATPases (SPCAs). Mammals …
[HTML][HTML] Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2
…, Q Wei, A Ali, RJ Fairclough… - The Journal of …, 2010 - Am Soc Clin Investig
Heterozygous mutations of GATA3, which encodes a dual zinc-finger transcription factor,
cause hypoparathyroidism with sensorineural deafness and renal dysplasia. Here, we have …
cause hypoparathyroidism with sensorineural deafness and renal dysplasia. Here, we have …
[HTML][HTML] Effect of Hailey-Hailey Disease mutations on the function of a new variant of human secretory pathway Ca2+/Mn2+-ATPase (hSPCA1)
RJ Fairclough, L Dode, J Vanoevelen… - Journal of Biological …, 2003 - ASBMB
ATP2C1, encoding the human secretory pathway Ca 2 + /Mn 2 + ATPase (hSPCA1), was
recently identified as the defective gene in Hailey-Hailey Disease (HHD), an autosomal …
recently identified as the defective gene in Hailey-Hailey Disease (HHD), an autosomal …
11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension
…, M Sagmeister, RJ Fairclough… - The Journal of …, 2021 - academic.oup.com
Background The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) determines
prereceptor metabolism and activation of glucocorticoids within peripheral tissues. Its …
prereceptor metabolism and activation of glucocorticoids within peripheral tissues. Its …
11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
Abstract Treatment options for idiopathic intracranial hypertension are limited. The enzyme
11β-hydroxysteroid dehydrogenase type 1 has been implicated in regulating cerebrospinal …
11β-hydroxysteroid dehydrogenase type 1 has been implicated in regulating cerebrospinal …
Progress in therapy for Duchenne muscular dystrophy
Duchenne muscular dystrophy is a devastating muscular dystrophy of childhood. Mutations
in the dystrophin gene destroy the link between the internal muscle filaments and the …
in the dystrophin gene destroy the link between the internal muscle filaments and the …
Public-private partnerships: compound and data sharing in drug discovery and development
Collaborative efforts between public and private entities such as academic institutions,
governments, and pharmaceutical companies form an integral part of scientific research, and …
governments, and pharmaceutical companies form an integral part of scientific research, and …
[HTML][HTML] The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326
Objectives The Glucokinase Regulatory Protein GKRP, encoded by GCKR, enables acute
regulation of liver glucokinase to support metabolic demand. The common human GCKR …
regulation of liver glucokinase to support metabolic demand. The common human GCKR …